Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Mergers, Acquisitions, and Partnerships news
(page 15)
25 March 2026
SPIE to acquire SGS Industrial Services to expand industrial services in Germany
Adds ~800 staff; strengthens electrical & mechanical installation capabilities; €180M 2025 revenue, >10% margins; self‑financed; EPS accretive; closing by June 2026 subject to approvals
25 March 2026
Merck to acquire Terns Pharmaceuticals, adding TERN‑701 for CML
Acquirer to buy target biotech at $53/share (~$6.7B equity, ~$5.7B net). Lead oral allosteric BCR::ABL1 TKI showed week‑24 molecular responses in Phase1/2; expected Q2 2026.
25 March 2026
ScottishPower secures £600m National Wealth Fund loan for EGL4 subsea link
2GW, 530 km HVDC subsea link will transmit Scottish low-cost power to England (1.5M homes), cut constraint costs, boost energy security, and support UK clean-power grid upgrades
25 March 2026
Novo Nordisk: UBT251 reduced HbA1c up to 2.16% at 24 weeks in Chinese Phase 2 T2D trial
Triple-agonist UBT251 (GLP-1/GIP/glucagon) induced up to 9.8% weight loss, improved BP and lipids vs placebo/semaglutide. Safety consistent with triple-G class; global phase-2 and China phase-3 planned
24 March 2026
MOL cleared by US to proceed with NIS majority‑stake acquisition talks
U.S. OFAC extended the negotiation license to 22 May 2026, allowing finalization of sale documents and U.S. banks' participation; deal would transfer 56.15% stake, pending approvals.
24 March 2026
WuXi Biologics posts record 2025 results
2025 revenue +16.7% to RMB21.8bn; gross margin +500bps to 46%; EBITDA +38%; net profit +45%; 209 new integrated projects; backlog US$23.7bn; bi-/multi-specifics >120% growth
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
24 March 2026
Equinor begins Raia pre‑salt gas drilling offshore Brazil
Six wells started 24 Mar with Valaris DS‑17 in ~2,900m water; recoverable >1bn boe; capacity 16m m3/day (~15% national demand); start‑up 2028; $9bn investment; FPSO ~6 kg CO2/boe.
24 March 2026
UPM and Paramelt launch bio-based paper food packaging
Bio-based paper food-packaging with strong grease barrier at low coat weights. Recyclable and home-compostable. Runs on existing packaging lines; suited to bakery/fast-food
24 March 2026
Teijin Aramid cuts drinking water use by 80% at Chemie Park Delfzijl
Cooling now uses industrial water from salt evaporation, cutting drinking-water use 80% (~300,000 m³), trimming total water use 10% and easing regional supply pressure.
24 March 2026
Veolia acquires Enviropacific for AUD220m to expand PFAS treatment in Australia
Boosts PFAS and soil remediation capacity in Australia via acquisition, integrating tech, field operations and infrastructure to scale cleanup, drive revenue growth and synergies.
23 March 2026
Equinor adds 230 MW Esquina do Vento wind complex in Brazil
Acquired ready-to-build 51-turbine onshore wind complex; expands onshore renewables and storage platform, supports integrated wind/solar/trading strategy, targets ~1 TWh/year and double-digit returns.
23 March 2026
TotalEnergies ends U.S. offshore wind projects, returns leases to DOI
Signed settlements to relinquish Carolina Long Bay and New York Bight offshore wind leases, recover fees and reinvest equal funds into U.S. gas/LNG and power, citing cost and affordability concerns.
23 March 2026
Sinopec Chairman Hou Qijun Meets TotalEnergies CEO Patrick Pouyanné
Meeting covered cooperation in oil and gas exploration and development, LNG trade, engineering services and new energy; a group vice president attended.
23 March 2026
Hou Qijun Meets BASF Chairman Kairi to Discuss Chemical Cooperation
On March 22 at headquarters, leaders held in-depth talks on deepening cooperation in the chemical sector; the group's vice general manager attended.
23 March 2026
Sinopec Among China's Top EV Charging Operators
2025 charging platform exceeded 5 billion kWh (~200% YoY). It is rapidly expanding charging and battery-swap networks with Aodong, NIO and CATL to broaden oil‑gas‑hydrogen‑electric services.
23 March 2026
GSK’s risvutatug rezetecan granted orphan drug designation for SCLC in Japan
Risvutatug rezetecan, a B7-H3–targeted ADC, showed durable responses in extensive‑stage SCLC in phase I ARTEMIS‑001; global phase III in relapsed ES‑SCLC is underway.
23 March 2026
KYORIN licenses novel drug candidates from UBE
Exclusive license grants development and commercialization rights with upfront, milestone and sales payments plus royalties. Partners will combine discovery compounds and R&D to accelerate treatments.
23 March 2026
Siemens expands industrial AI OS, unveils new tech and Alibaba Cloud partnership
Introduces 26 edge, automation and control products, cloud-enabled CAE, DC circuit breakers, AI cooling for data centers, upgraded PLCs, servo systems and predictive maintenance apps.
20 March 2026
TotalEnergies and Holcim open Europe’s largest floating solar plant for self-consumption
31 MW floating solar on a rehabilitated Obourg quarry lake produces 30 GWh/yr for onsite industrial self-consumption; over 700 m of directional drilling links panels to the substation.
20 March 2026
Moeve and Naturgy double savings on fuel, gas and electricity
14-day promo (Mar 24–Apr 6): registered users save 10–67¢/L (app + card + Multienergy combos); two 42L fills yield €8–56; professionals get extra 5¢/L.
20 March 2026
FUCHS posts solid FY 2025 results
FY2025: sales €3.56bn, EBIT €435m; EPS +2%; dividend +5% to €1.23/€1.22; free cash flow €316m. 2026 outlook: sales ~€3.7bn, EBIT ~€450m
19 March 2026
EU invests €330m in fusion and nuclear R&D and skills
Work Programme funds fusion-to-grid R&D, a PPP, startups, skills and facilities; supports fission research on waste, safety, materials, medical isotopes and talent mobility.
19 March 2026
Aptar’s Unidose Nasal Powder System Used in ENA Respiratory Phase II INNA‑051 Study
Powder nasal device used in a Phase II trial of a once-weekly spray to assess safety, tolerability and reduction of symptomatic infections; device offers single-dose precision and moisture protection.
19 March 2026
OMV and ADNOC delay BGI listing, exchange offer and capital increase to 2027
Timing aligned to a 2027 capital increase; 2026 dividend cut will lower parent payout by ~€0.6–0.7/sh (payout USD250m vs USD500m). Further support measures possible.
19 March 2026
ADNOC and OMV advance formation of Borouge Group International AG
Agreement allows marketing of B4 volumes, adds ~$400M net over 3 years (~10% EPS accretion), supports 16.2 fils dividend, targets strong credit ratings; transactions close ~Mar 2026.
19 March 2026
GSK: Lynavoy (linerixibat) FDA-approved for cholestatic pruritus in PBC
FDA approved linerixibat for cholestatic pruritus in adults with PBC after GLISTEN phase III showed rapid, sustained itch and sleep improvements. Common AEs: diarrhea, abdominal pain.
19 March 2026
Eni reorganises Plenitude ownership, prompting deconsolidation
Raise ~€1.5bn via non‑pro rata issue (pre‑money €10.75bn). New joint control; major holder ~65%. Funds to back 15 GW and 15M customers by 2030. Subject to approvals.
19 March 2026
Eni 2026–2030 Plan
Consistent strategy: strong E&P project pipeline driving 3-4% production growth to 2030, self-funding Transition units, CFFO rising to €17bn, €40-45bn FCF 2026-30, lower gearing and higher payouts.
19 March 2026
bp to sell Gelsenkirchen refinery to Klesch Group
Sale of Gelsenkirchen refinery raises structural cost-cut target by ~$1bn to $6.5-7.5bn by 2027, strengthens balance sheet, is free-cash-flow accretive; 12Mtpa, ~1,800 staff; close H2 2026.
19 March 2026
Equinor Annual Report 2025
Record production and strong cash results in 2025; safety improved; adjusted operating income $27.6B; production 2,137 mboe/d; renewables +25%; emissions −34% since 2015.
← Previous
Next →
